1. Home
  2. BPYPO vs VCEL Comparison

BPYPO vs VCEL Comparison

Compare BPYPO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Property Partners L.P.

BPYPO

Brookfield Property Partners L.P.

HOLD

Current Price

$14.50

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

BUY

Current Price

$36.60

Market Cap

2.0B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BPYPO
VCEL
Founded
N/A
1989
Country
Bermuda
United States
Employees
30200
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.0B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
BPYPO
VCEL
Price
$14.50
$36.60
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$60.40
AVG Volume (30 Days)
N/A
592.9K
Earning Date
N/A
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
N/A
$258,716,999.00
Revenue This Year
N/A
$17.86
Revenue Next Year
N/A
$18.55
P/E Ratio
N/A
$148.17
Revenue Growth
N/A
14.05
52 Week Low
N/A
$29.24
52 Week High
N/A
$63.00

Technical Indicators

Market Signals
Indicator
BPYPO
VCEL
Relative Strength Index (RSI) 46.53 45.31
Support Level $14.20 $35.85
Resistance Level $14.52 $42.68
Average True Range (ATR) 0.21 1.63
MACD 0.01 -0.32
Stochastic Oscillator 51.85 12.60

Price Performance

Historical Comparison
BPYPO
VCEL

About BPYPO Brookfield Property Partners L.P.

Brookfield Property Partners LP owns, operates, and invests in commercial properties in North America, Europe, Australia, and Brazil. The company focuses on being an owner and operator of real estate, providing investors with diversified exposure to some of the iconic properties and acquiring high-quality assets at a discount to replacement cost or intrinsic value. Its operating segment includes Core Office, Core Retail, LP Investments, and Corporate Segments. The company operates in various sectors such as the office sector, retail sector, industrial, multifamily, hospitality, triple net lease, and corporate sector. It generates a majority of revenue from the LP Investments segment.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: